Omada Health, Inc. (NASDAQ:OMDA – Get Free Report)’s stock price was down 7.1% on Friday . The company traded as low as $19.31 and last traded at $19.9740. 209,893 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 1,242,573 shares. The stock had previously closed at $21.50.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on OMDA shares. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Needham & Company LLC restated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a research report on Friday. Robert W. Baird raised their price objective on Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 12th. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Barclays boosted their target price on Omada Health from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Friday. Eleven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $26.67.
View Our Latest Stock Report on Omada Health
Omada Health Stock Performance
Omada Health (NASDAQ:OMDA – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The firm had revenue of $87.83 million during the quarter, compared to analysts’ expectations of $80.93 million. As a group, research analysts expect that Omada Health, Inc. will post 0.09 EPS for the current fiscal year.
Insider Transactions at Omada Health
In related news, CEO Sean Duffy sold 25,886 shares of Omada Health stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total value of $587,094.48. Following the sale, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. This trade represents a 5.91% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Steven Cook sold 33,000 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $19.89, for a total transaction of $656,370.00. Following the transaction, the chief financial officer directly owned 133,359 shares of the company’s stock, valued at $2,652,510.51. This represents a 19.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 265,923 shares of company stock valued at $5,708,519. 6.38% of the stock is owned by corporate insiders.
Institutional Trading of Omada Health
Hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. acquired a new position in Omada Health during the second quarter worth $32,000. Bellevue Group AG raised its position in shares of Omada Health by 0.7% in the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after purchasing an additional 1,791 shares during the period. Quarry LP acquired a new position in Omada Health in the 4th quarter valued at about $29,000. Barclays PLC grew its position in shares of Omada Health by 14.6% in the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after purchasing an additional 1,888 shares during the last quarter. Finally, Versant Capital Management Inc increased its stake in shares of Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after purchasing an additional 2,283 shares during the period.
About Omada Health
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Featured Stories
- Five stocks we like better than Omada Health
- Amgen Drops 10% on a Trial It Didn’t Even Run
- Oracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in Earnings
- TSMC Revenue Jumps 53% in August, Signaling Strong AI Chip Demand
- This AI ETF Is Missing the Biggest AI Winners
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
